- Home
- CLRO vs NERV Comparison
CLRO vs NERV Comparison
Compare CLRO & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- NERV
- Stock Information
- Founded
- CLRO 1983
- NERV 2007
- Country
- CLRO United States
- NERV United States
- Employees
- CLRO N/A
- NERV N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- CLRO Technology
- NERV Health Care
- Exchange
- CLRO Nasdaq
- NERV Nasdaq
- Market Cap
- CLRO 12.5M
- NERV 12.4M
- IPO Year
- CLRO N/A
- NERV 2014
- Fundamental
- Price
- CLRO $0.53
- NERV $1.61
- Analyst Decision
- CLRO
- NERV Hold
- Analyst Count
- CLRO 0
- NERV 1
- Target Price
- CLRO N/A
- NERV $5.00
- AVG Volume (30 Days)
- CLRO 25.2K
- NERV 7.7K
- Earning Date
- CLRO 05-19-2025
- NERV 05-20-2025
- Dividend Yield
- CLRO 94.34%
- NERV N/A
- EPS Growth
- CLRO N/A
- NERV N/A
- EPS
- CLRO N/A
- NERV 0.19
- Revenue
- CLRO $11,386,000.00
- NERV N/A
- Revenue This Year
- CLRO N/A
- NERV N/A
- Revenue Next Year
- CLRO N/A
- NERV N/A
- P/E Ratio
- CLRO N/A
- NERV $8.42
- Revenue Growth
- CLRO N/A
- NERV N/A
- 52 Week Low
- CLRO $0.43
- NERV $1.15
- 52 Week High
- CLRO $1.40
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- CLRO 46.24
- NERV 46.58
- Support Level
- CLRO $0.51
- NERV $1.65
- Resistance Level
- CLRO $0.59
- NERV $1.75
- Average True Range (ATR)
- CLRO 0.04
- NERV 0.08
- MACD
- CLRO 0.00
- NERV -0.00
- Stochastic Oscillator
- CLRO 38.27
- NERV 31.03
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.